Ocugen Inc (OCGN) is a biotechnology company listed on NASDAQ.
Latest reported OCGN revenue for 2026-06-30 was $3.0M. Net income was -$44.1M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
Use this OCGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OCGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OCGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Ocugen Inc even when a live quote feed is slow.
Latest cached year on this hub. Full OCGN income, balance, and cash tables.